Ina Müller

579 total citations
13 papers, 475 citations indexed

About

Ina Müller is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ina Müller has authored 13 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Oncology. Recurrent topics in Ina Müller's work include Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (4 papers). Ina Müller is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (4 papers). Ina Müller collaborates with scholars based in Germany, United States and France. Ina Müller's co-authors include Jan Dörrie, Niels Schaft, Gerold Schuler, Eckhart Kämpgen, Verena Beck, Detlef Dieckmann, Erwin Schultz, Ilka Knippertz, Dirk M. Nettelbeck and Alexander Steinkasserer and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Ina Müller

13 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ina Müller Germany	9	290	275	208	88	41	13	475
Anthony Leonardi United States	6	292 1.0×	377 1.4×	139 0.7×	108 1.2×	72 1.8×	10	518
Andrea Quaiser Germany	11	195 0.7×	342 1.2×	150 0.7×	78 0.9×	42 1.0×	20	459
Won‐Ju Kim South Korea	10	203 0.7×	180 0.7×	152 0.7×	53 0.6×	63 1.5×	23	414
Hannah Gornall United Kingdom	8	189 0.7×	161 0.6×	149 0.7×	60 0.7×	39 1.0×	9	331
Mina O. Seedhom United States	8	271 0.9×	209 0.8×	148 0.7×	49 0.6×	48 1.2×	14	503
Ting Lu United States	11	291 1.0×	336 1.2×	95 0.5×	87 1.0×	56 1.4×	15	522
Aleksei Titov Russia	7	147 0.5×	214 0.8×	122 0.6×	70 0.8×	61 1.5×	13	368
Lisa Marie Serrano United States	8	268 0.9×	459 1.7×	116 0.6×	169 1.9×	89 2.2×	9	543
Cary Hsu United States	9	250 0.9×	309 1.1×	185 0.9×	135 1.5×	35 0.9×	11	463
Vidya Chandramohan United States	7	150 0.5×	165 0.6×	108 0.5×	91 1.0×	16 0.4×	17	337

Countries citing papers authored by Ina Müller

Since Specialization

Citations

This map shows the geographic impact of Ina Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Müller more than expected).

Fields of papers citing papers by Ina Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Müller. The network helps show where Ina Müller may publish in the future.

Co-authorship network of co-authors of Ina Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Müller. A scholar is included among the top collaborators of Ina Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Müller. Ina Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Siebert, Nikolai, Christian Fuglesang S. Jensen, Karoline Ehlert, et al.. (2016). Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD₂ antibody ch14.18/CHO show higher ADCC levels and improved event-free survival. OncoImmunology. 5(11). e1235108–e1235108. 40 indexed citations

Lode, Holger N., Dominique Valteau‐Couanet, Alberto Garaventa, et al.. (2016). Abstract A032: Immunotherapy with ch14.18/CHO in combination with IL2 is active and effective in high-risk relapsed/refractory neuroblastoma patients. Cancer Immunology Research. 4(1_Supplement). A032–A032. 1 indexed citations

Dörrie, Jan, Christian Hofmann, Ina Müller, et al.. (2014). Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation. PLoS ONE. 9(10). e109944–e109944. 22 indexed citations

Lode, Holger N., Christian Fuglesang S. Jensen, Nikolai Siebert, et al.. (2014). Abstract CT410: Immune activation, clinical response and survival following long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 in high-risk neuroblastoma patients. Cancer Research. 74(19_Supplement). CT410–CT410. 3 indexed citations

Lode, Holger N., Nikolai Siebert, Silke Kietz, et al.. (2013). Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients. Journal for ImmunoTherapy of Cancer. 1(S1). 1 indexed citations

Knippertz, Ilka, Jan Dörrie, Niels Schaft, et al.. (2011). Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. International Journal of Hyperthermia. 27(6). 591–603. 68 indexed citations

Dörrie, Jan, Niels Schaft, Ina Müller, et al.. (2007). Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes. Cancer Immunology Immunotherapy. 57(4). 467–477. 32 indexed citations

Hesse, Andrea, Ina Müller, Eckhart Kämpgen, et al.. (2007). Modulation of viability and maturation of human monocyte‐derived dendritic cells by oncolytic adenoviruses. International Journal of Cancer. 122(1). 219–229. 12 indexed citations

Schaft, Niels, Jan Dörrie, Verena Beck, et al.. (2005). Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. The Journal of Immunology. 174(9). 5884–5884. 3 indexed citations

10.

Schaft, Niels, Jan Dörrie, Verena Beck, et al.. (2005). Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation. The Journal of Immunology. 174(5). 3087–3097. 115 indexed citations

11.

Schaft, Niels, Jan Dörrie, Ina Müller, et al.. (2005). A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes. Cancer Immunology Immunotherapy. 55(9). 1132–1141. 92 indexed citations

12.

Atzpodien, Jens, K. Neuber, Darab Kamanabrou, et al.. (2002). Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM). British Journal of Cancer. 86(2). 179–184. 68 indexed citations

13.

Hoffmann, Reinhard, Ina Müller, K. Neuber, et al.. (1998). Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a. British Journal of Cancer. 78(8). 1076–1080. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact